EXHIBIT 2.2Escrow Agreement • May 18th, 1999 • Geron Corporation • Pharmaceutical preparations • New York
Right to Purchase _________ Shares of Common Stock, par value $0.001 per share COMMON STOCK PURCHASE WARRANT D THIS CERTIFIES THAT, for value received, _____________ or its registered assigns (the "Holder"), is entitled to purchase from Geron...Geron Corp • March 1st, 2007 • Pharmaceutical preparations • Delaware
RECITALSSecurities Purchase Agreement • May 15th, 2000 • Geron Corporation • Pharmaceutical preparations • California
EXHIBIT C TO SECURITIES PURCHASE AGREEMENT REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of June 29, 2000, by and between Geron Corporation, a Delaware corporation, with its headquarters located at 230...Registration Rights Agreement • July 6th, 2000 • Geron Corporation • Pharmaceutical preparations • Delaware
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 240.24b-2 Agreement No. 99-0027 LICENSE AGREEMENT This Agreement is made effective the 23rd day of April, 1999, by and between...License Agreement • January 21st, 2000 • Geron Corporation • Pharmaceutical preparations
EXHBIT 10.1 FIFTH AMENDMENT TO LEASE THIS FIFTH AMENDMENT TO LEASE ("Fifth Amendment") is made this 19th day of March, 2008 (the "Effective Date"), between DAVID D. BOHANNON ORGANIZATION, a California corporation, herein referred to as "Landlord", and...Lease • April 30th, 2008 • Geron Corp • Pharmaceutical preparations • California
EXHIBIT 4.1 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS, AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR...Geron Corp • October 30th, 2007 • Pharmaceutical preparations • New York
EXHIBIT 4.2 FORM OF 2006 A WARRANT AMENDMENT AMENDMENT NO. 1 TO COMMON STOCK PURCHASE WARRANT A This AMENDMENT NO. 1 TO COMMON STOCK PURCHASE WARRANT A dated as of December 20, 2007 (this "Amendment"), among Geron Corporation, a Delaware corporation...Geron Corp • December 21st, 2007 • Pharmaceutical preparations
Right to Purchase _______ Shares of Common Stock, par value $0.001 per share COMMON STOCK PURCHASE WARRANT C THIS CERTIFIES THAT, for value received, ________________ (the "Holder") or its registered assigns, is entitled to purchase from Geron...Geron Corp • December 15th, 2006 • Pharmaceutical preparations • Delaware
Underwriting Agreement, Dated May 21, 2020 GERON CORPORATION (a Delaware corporation) 107,049,375 Shares of Common Stock Pre-Funded Warrants to Purchase up to 8,335,239 Shares of Common Stock Common Warrants to Purchase up to 57,692,307 Shares of...Underwriting Agreement • May 26th, 2020 • Geron Corp • Pharmaceutical preparations • New York
Notwithstanding the foregoing, and subject to the conditions in this paragraph, the undersigned may transfer the Lock-Up Securities without the prior written consent of the Representatives, provided that (1) the Representatives receive a signed lock-up agreement for the balance of the Lock-Up Period from each donee, trustee, distributee, or transferee, as the case may be, (2) any such transfer shall not involve a disposition for value, (3) in the case of clauses (i) through (iii) and (v) below, such transfers are not required to be reported with the Securities and Exchange Commission on Form 4 in accordance with Section 16(a) Exchange Act during the Lock-Up Period, and (4) the undersigned does not otherwise voluntarily effect any public filing or report regarding such transfers during the Lock-Up Period:
1 EXHIBIT 1.1 GERON CORPORATION 3,000,000 Shares of Common Stock Underwriting AgreementGeron Corporation • April 7th, 2000 • Pharmaceutical preparations • New York
1 EXHIBIT 10.41Registration Rights Agreement • December 17th, 1998 • Geron Corporation • Pharmaceutical preparations • New York
EXHIBIT 4.1 COMMON STOCK PURCHASE AGREEMENT THIS COMMON STOCK PURCHASE AGREEMENT ("Agreement") is made and entered into as of August 13, 2008 (the "Effective Date"), by and between GERON CORPORATION, a Delaware corporation having its principal place...Common Stock Purchase Agreement • August 21st, 2008 • Geron Corp • Pharmaceutical preparations • California
ARTICLE I DEFINITIONSEmployment Agreement • April 30th, 2003 • Geron Corporation • Pharmaceutical preparations • California
EXHIBIT 10.38 SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT (this "AGREEMENT"), dated as of March 27, 1998, by and among Geron Corporation, a Delaware corporation, with headquarters located at 230 Constitution Drive, Menlo Park,...Securities Purchase Agreement • April 2nd, 1998 • Geron Corporation • Pharmaceutical preparations • Delaware
EXHIBIT 1.1Underwriting Agreement • October 29th, 2003 • Geron Corporation • Pharmaceutical preparations • New York
EXHBIT 4.1 FORM OF 2004 A WARRANT AMENDMENT AMENDMENT NO. 1 TO COMMON STOCK PURCHASE WARRANT A This AMENDMENT NO. 1 TO COMMON STOCK PURCHASE WARRANT A dated as of December 20, 2007 (this "Amendment"), among Geron Corporation, a Delaware corporation...Geron Corp • December 21st, 2007 • Pharmaceutical preparations
Exhibit4.4 Amended and Restated Series D-2 Stock Purchase Warrant, dated as of May 23, 2003 ------------------------------------------------------------------ --------------Geron Corporation • May 27th, 2003 • Pharmaceutical preparations
andRights Agreement • July 23rd, 2001 • Geron Corporation • Pharmaceutical preparations • California
WARRANT -------Agreement • October 15th, 2003 • Geron Corporation • Pharmaceutical preparations • New York
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 240.24B-2 AMENDMENT TO LICENSE AGREEMENT This Agreement is made effective October 1, 1999, by and between Wisconsin Alumni Research...License Agreement • November 15th, 1999 • Geron Corporation • Pharmaceutical preparations
EXHIBIT 10.40Securities Purchase Agreement • December 17th, 1998 • Geron Corporation • Pharmaceutical preparations • New York
WARRANT -------Geron Corporation • October 15th, 2003 • Pharmaceutical preparations • New York
GERON CORPORATION AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF __________ GERON CORPORATION FORM OF PREFERRED STOCK WARRANT AGREEMENTWarrant Agreement • January 4th, 2023 • Geron Corp • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between GERON CORPORATION, a Delaware corporation (the “Company ”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Right to Purchase 333,935 Shares of Common Stock, par value $0.001 per share GERON CORPORATION AMENDED AND RESTATED SERIES D-1 STOCK PURCHASE WARRANT Registered Owner: This warrant is a duly authorized warrant (the "Warrant") of Geron Corporation, a...Geron Corporation • November 14th, 2001 • Pharmaceutical preparations
AMENDMENT NO. 1 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 1st, 1999 • Geron Corporation • Pharmaceutical preparations • New York
Agreement No. 02-0273 LICENSE AGREEMENT This Agreement is made effective the 8th day of January, 2002, by and between Wisconsin Alumni Research Foundation (hereinafter called "WARF"), a nonstock, nonprofit Wisconsin corporation, and Geron Corporation...Confidential Treatment • January 18th, 2002 • Geron Corporation • Pharmaceutical preparations
FORM OF WARRANTGeron Corporation • May 15th, 2000 • Pharmaceutical preparations • California
EXHIBIT 4.6 FORM OF INDENTURE TO BE ENTERED INTO BETWEEN THE COMPANY AND A TRUSTEE TO BE NAMED GERON CORPORATIONGeron Corporation • May 5th, 2004 • Pharmaceutical preparations • New York
EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 6th, 2000 • Geron Corporation • Pharmaceutical preparations • Delaware
GERON CORPORATION AND _____________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF __________Common Stock Warrant Agreement • September 4th, 2020 • Geron Corp • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “ Agreement ”), dated as of [●], between GERON CORPORATION , a Delaware corporation (the “ Company ”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “ Warrant Agent ”).
GERON CORPORATION AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF __________Warrant Agreement • January 4th, 2023 • Geron Corp • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “ Agreement ”), dated as of [•], between GERON CORPORATION , a Delaware corporation (the “ Company ”) and [•], a [corporation] [national banking association]organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “ Warrant Agent ”).
17,391,305 Shares of Common Stock par value $0.001 2,608,695 Over-Allotment Shares GERON CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2010 • Geron Corp • Pharmaceutical preparations • New York
1 EXHIBIT 2.1Sale and Purchase Agreement • May 18th, 1999 • Geron Corporation • Pharmaceutical preparations
EXHIBIT 4.1Registration Rights Agreement • May 18th, 1999 • Geron Corporation • Pharmaceutical preparations • Delaware
